Takashi Mizuno

Associate Professor, Senior Lecturer

Nagoya University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Takashi Mizuno is an Associate Professor and Senior Lecturer at Nagoya University, Japan. His research primarily focuses on hepato-biliary-pancreatic cancers, with recent work exploring areas such as biliary epithelium regeneration, HER2 overexpression in intraductal papillary neoplasms, and surgical outcomes related to muscle mass in major hepatectomy procedures. He contributes significantly to understanding the impacts of various surgical and pathological factors on patient recovery and disease prognosis.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Shinji Naganawa

Professor and chairman

Nagoya Daigaku

JAPAN

View details

Hiroki Kawashima

Professor

Nagoya University Hospital

JAPAN

View details

Masanao Nakamura

Nagoya University

JAPAN

View details

Anita Balakrishnan

Cambridge University Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Yasuyuki Mizutani

Nagoya University

JAPAN

View details

Taisuke Baba

Assistant Prof

Nagoya University

JAPAN

View details

Ramón Charco Torra

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takashi Mizuno

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Dedifferentiation-Dependent Regeneration of the Biliary Ductal Epithelium in Response to Hepatic Injury in TFF1-Deficient Mice

Reappraisal of carcinoma in situ residue at the bile duct margin: a single-center review of 681 patients with perihilar cholangiocarcinoma

Prognostic Impact of HER2 Overexpression in Intraductal Papillary Neoplasm of the Bile Duct

Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic cancer: a prospective comparative cohort trial

Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan

Utility of modified pancreaticoduodenectomy (Hi-cut PD) for middle-third cholangiocarcinoma: an alternative to hepatopancreaticoduodenectomy

Liver remnant volume to body weight ratio of 0.65% as a lower limit in right hepatic trisectionectomy with bile duct resection

Subsegmental approaches to S7: anatomic laparoscopic transdiaphragmatic and nonanatomic robotic transthoracic

Impact of preoperative muscle mass and quality on surgical outcomes in patients undergoing major hepatectomy for perihilar cholangiocarcinoma

Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization

Is minimally invasive surgery for large gastric GIST actually safe? A comparative analysis of short- and long-term outcomes

Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma—a word of caution: a propensity score matched analysis using the national cancer database

Reply to comment on “Adjuvant S‐1 vs gemcitabine for node‐positive perihilar cholangiocarcinoma”

A long-term survivor of advanced retroperitoneal dedifferentiated liposarcoma: a successful multimodal approach with extended resection and chemotherapy

A proposal of drain removal criteria in hepatobiliary resection

Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma

Combined Vascular Resection for Locally Advanced Perihilar Cholangiocarcinoma

Comparison of an Inside Stent and a Fully Covered Self-Expandable Metallic Stent as Preoperative Biliary Drainage for Patients with Resectable Perihilar Cholangiocarcinoma

Reply to comment on "Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma"

Collaborators (7)

Shinji Naganawa

Hiroki Kawashima

Masanao Nakamura

Anita Balakrishnan

Yasuyuki Mizutani

Taisuke Baba

Ramón Charco Torra

Make your next move.